Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Liver save search
Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer
Published: 2022-07-26 (Crawled : 13:20) - biospace.com/
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.25%
H: 200.0%
C: 200.0%
drug candidate research liver pre-clinical therapy cancer publication
Aemetis Begins Deliveries of Carbon Dioxide Under Supply Agreement With New Messer CO2 Plant
Published: 2020-05-01 (Crawled : 14:52) - globenewswire.com
AMTX | $3.75 -4.34% 51K
|
Process Industries
|
| O: 29.31%
H: 129.33%
C: 13.33%
liver
Exela Technologies Wins $90 Million Contract for Cloud-Hosted PCH Global, Delivering Healthcare Solutions for Major US Insurer
Published: 2021-03-09 (Crawled : 13:18) - globenewswire.com
XELA | $1.96 14K
|
Technology Services
|
| O: 49.7%
H: 122.67%
C: 86.64%
contract liver
Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3
Published: 2021-07-21 (Crawled : 12:00) - biospace.com/
LEXX | $2.2 2K
|
Health Technology
|
| O: 27.16%
H: 49.16%
C: 0.72%
liver
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
OCEA | $1.415 -4.39% -4.59% 4.2K
|
|
| O: 2.6%
H: 36.71%
C: 11.39%
first liver presentation global meeting therapeutics study
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
Published: 2021-06-22 (Crawled : 13:00) - globenewswire.com
DDD 4 | $3.41 -1.73% 81K
|
Producer Manufacturing
|
| O: 2.49%
H: 30.24%
C: 24.56%
CLGN | $5.41 500
|
Health Technology
|
| O: -0.55%
H: 21.07%
C: 13.24%
treatment liver
Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
Published: 2023-11-10 (Crawled : 14:00) - globenewswire.com
HEPA | $1.32 -11.41% -7.19% 0
|
Health Technology
|
| O: 2.05%
H: 29.77%
C: 1.34%
liver conference review pharmaceuticals trial phase 2
Q BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancer
Published: 2022-03-16 (Crawled : 14:00) - biospace.com/
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 6.0%
H: 27.17%
C: 2.12%
drug research liver cancer
Critical Solutions, Inc. (CSLI) Acquires Brother Buds™ Medical Cannabis Delivery Service and Brand
Published: 2021-10-26 (Crawled : 14:00) - globenewswire.com
CSLI | $0.0001 1700.0% 850K
|
|
| O: -2.06%
H: 25.26%
C: 5.26%
cannabis liver
Workhorse and GreenPower Sign Supply Agreement for Delivery of 1,500 GreenPower EV Star Cab and Chassis for Workhorse W750 Step Vans
Published: 2022-03-01 (Crawled : 13:30) - greenpowerbus.com
WKHS | $0.1555 -3.24% 850K
|
Producer Manufacturing
|
| O: 0.0%
H: 22.96%
C: 21.82%
GP | $1.75 2.84% 98K
|
Consumer Durables
|
| O: -1.9%
H: 8.23%
C: 4.84%
liver 500 star work
Altimmune Announces Positive Topline Results from 24-Week (12-Week Extension) Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
Published: 2022-12-20 (Crawled : 12:20) - globenewswire.com
ALT | $6.83 -3.53% 330K
|
Commercial Services
|
| O: -4.19%
H: 21.16%
C: 21.06%
liver disease topline trial positive results
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022
Published: 2022-06-17 (Crawled : 12:00) - globenewswire.com
ALT | $6.83 -3.53% 330K
|
Commercial Services
|
| O: -7.71%
H: 20.69%
C: 19.63%
liver presentation international
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022Presentation to be highlighted in the Best of International Liver Congress
Published: 2022-06-17 (Crawled : 16:00) - biospace.com/
ALT | $6.83 -3.53% 330K
|
Commercial Services
|
| O: -7.71%
H: 20.69%
C: 19.63%
liver presentation international
Preclinical Data Show Potential for Use of Genprex’s ONCOPREX® Nanoparticle Delivery System in Treating Colon Cancer
Published: 2022-01-27 (Crawled : 18:00) - biospace.com/
GNPX | $2.21 58
|
Health Technology
|
| O: 0.52%
H: 20.51%
C: -5.13%
oncoprex liver system preclinical potential cancer pre-clinical
Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
Published: 2021-07-26 (Crawled : 13:00) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 53.42%
H: 20.24%
C: -17.86%
cancer drug patent drug delivery liver granted grant
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s LaboratoryHemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced molecular screening technology
Published: 2021-08-26 (Crawled : 18:00) - biospace.com/
PRPO 4 | $5.86 -4.72% -0.82% 0
|
Health Technology
|
| O: 1.74%
H: 19.14%
C: 3.71%
molecular technology liver diagnostics diagnostic
Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
MC | $53.99 -1.12% 0.5% 6.1K
|
Finance
|
| O: 0.06%
H: 1.22%
C: 0.16%
COLL | $35.48 -1.28% -1.27% 88
|
Health Technology
|
| O: 2.33%
H: 18.5%
C: 10.56%
ces liver
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
MC | $53.99 -1.12% 0.5% 6.1K
|
Finance
|
| O: 0.06%
H: 1.22%
C: 0.16%
COLL | $35.48 -1.28% -1.27% 88
|
Health Technology
|
| O: 2.33%
H: 18.5%
C: 10.56%
ces deal liver
CleanSpark Announces Additional 1,000 Unit ASIC Bitcoin Miner Order for January Delivery
Published: 2020-12-22 (Crawled : 15:07) - prnewswire.com
CLSK | $18.4 -6.98% 5.5M
|
Miscellaneous
|
| O: 1.03%
H: 18.41%
C: 16.69%
liver order
Marrone Bio Innovations’ New Plant Health Product, Pacesetter®, Delivers a Six to One Return on Investment for Corn and Soybean Farmers
Published: 2021-02-08 (Crawled : 15:01) - globenewswire.com
MBII | $0.7981 -20.19% 1.49%
|
Process Industries
|
| O: 4.26%
H: 18.37%
C: 10.2%
liver
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
LICN | $1.0 78.57% 3.3M
|
BOF | $1.915 63.68% 620K
|
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
ILAG | $0.669 23.89% 13M
|
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.